MBNL1/2, RBFOX2 and QKI were downregulated in most of the cancer types and, as expected, their motifs were enriched in these cancer types upstream to exons with higher exclusion and downstream to exons with higher inclusion in cancer (62,72–75). Here, RBFOX2 is linked to cancer.